Plasma vascular endothelial growth factor level is elevated in patients with multivessel coronary artery disease

Clinical Cardiology

Volumn 27, Issue 5, 2004, Pages 281-286

  Nakajima, Kei ^a,c   Tabata, Shinji ^a   Yamashita, Takeshi ^b   Kusuhara, Masatoshi ^a   Arakawa, Koh ^a   Ohmori, Reiko ^a   Yonemura, Atsushi ^a   Higashi, Kenji ^a   Ayaori, Makoto ^a   Nakamura, Haruo ^b   Ohsuzu, Fumio ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Mitsukoshi Health and Welfare Foundation   (Japan)

^c Japan Air Self Defense Force   (Japan)

Author keywords

Atherosclerosis; Coronary artery disease; Cytokine; Ischemia; Severity; Vascular endothelial growth factor

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; SOLUBLE INTERCELLULAR ADHESION MOLECULE 1; SOLUBLE VASCULOTROPIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MULTIVESSEL CORONARY ARTERY DISEASE; RISK FACTOR;

EID: 2542560424     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960270509     Document Type: Article

References (34)

1. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-1309
2. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989;84:1470-1478
3. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25
4. Klagsbrun M, D'Amore PA: Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 1996;7:259-270
5. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-845
6. Brogi E, Wu T, Namiki A, Isner JM: Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994;90:649-652
7. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E: Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: Implications for coronary angiogenesis. Cardiovasc Res 1994;28:1176-1179
8. Fuhrmann-Benzakein E, Ma MN, Rubbia-Brandt L, Mentha G, Ruefenacht D, Sappino AP, Pepper MS: Elevated levels of angiogenic cytokines in the plasma of cancer patients. Int J Cancer 2000;85:40-45
9. Duque JL, Loughlin KR, Adam RM, Kantoff PW, Zurakowski D, Freeman MR: Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer. Urology 1999;54:523-527
10. Agrawal R, Conway GS, Sladkevicius P, Payne NN, Bekir J, Campbell S, Tan SL, Jacobs HS: Serum vascular endothelial growth factor (VEGF) in the normal menstrual cycle: Association with changes in ovarian and uterine Doppler blood flow. Clin Endocrinol (Oxf) 1999;50:101-106
11. Sharkey AM, Cooper JC, Balmforth JR, McLaren J, Clark DE, Charnock-Jones DS, Morris NH, Smith SK: Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Eur J Clin Invest 1996;26:1182-1185
12. Harada M, Mitsuyama K, Yoshida H, Sakisaka S, Taniguchi E, Kawaguchi T, Ariyoshi M, Saiki T, Sakamoto M, Nagata K, Sata M, Matsuo K, Tanikawa K: Vascular endothelial growth factor in patients with rheumatoid arthritis. Scand J Rheumatol 1998;27:377-380
13. Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR: Vascular permeability factor/vascular endothelial growth factor: An important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 1995;107:233-235
14. Gensini GG: A more meaningful scoring system for determining the severity of coronary heart disease (letter). Am J Cardiol 1983;51:606
15. Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, Kyriakopoulos A: The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993;171:223-229
16. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr, Boerwinkle E: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The atherosclerosis risk in communities (ARIC) study. Circulation 1997;96:4219-4225
17. Peter K, Nawroth P, Conradt C, Nordt T, Weiss T, Boehme M, Wunsch A, Allenberg J, Kubler W, Bode C: Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol 1997;17:505-512
18. Superko HR, Krauss RM: Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management. Circulation 1994;90:1056-1069
19. Steinberg D, Gotto AM Jr: Preventing coronary artery disease by lowering cholesterol levels: Fifty years from bench to bedside. J Am Med Assoc 1999;282:2043-2050
20. Arakawa K, Isoda K, Sugiyabu Y, Fukuda M, Nishizawa K, Shibuya T, Nakamura H: Intimal proliferation after stenting reflected by increased stent-to-vessel cross-sectional area ratio: Serial intravascular ultrasound study. J Cardiol 1998;32:379-389
21. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N: Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992 Dec;267:26031-26037
22. Kondo S, Matsumoto T, Yokoyama Y, Ohmori I, Suzuki H: The shortest isoform of human vascular endothelial growth factor/vascular permeability factor (VEGF/VPF121) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeability. Biochim Biophys Acta 1995 Feb; 1243:195-202
23. Lochen ML: The Tromso study: The prevalence of exercise-induced silent myocardial ischaemia and relation to risk factors for coronary heart disease in an apparently healthy population. Eur Heart J 1992;13:728-731
24. Osterspey A, Treis-Muller I, Gunther H, Eggeling T, Siglow C, Gedicke V, Hopp H, Diewitz M, Osterhues H, Hilger HH: Silent ischaemia in asymptomatic "healthy" individuals with coronary risk factors. Eur Heart J 1988; (suppl N):65-69
25. Reardon MF, Nestel PJ, Craig IH, Harper RW: Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation 1985;71:881-888
26. Sullivan DR, Marwick TH, Freedman SB: A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 1990;119:1262-1267
27. Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, Doi K, Ogawa Y, Tamura N, Takaya K, Igaki T, Yamashita J, Chun TH, Masatsugu K, Becker AE, Nakao K: Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: Possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998;98:2108-211
28. Moussa I, Moses JW: Angiogenesis for treatment of ischemic heart disease: Should we worry about progression of atherosclerosis (letter)? Circulation 1999;100:e109
29. O'Brien ER, Garvin MR, Dev R, Stewart DK, Hinohara T, Simpson JB, Schwartz SM: Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol 1994;145:883-894
30. Ogawa H, Suefuji H, Soejima H, Nishiyama K, Misumi K, Takazoe K, Miyamoto S, Kajiwara I, Sumida H, Sakamoto T, Yoshimura M, Kugiyama K, Yasue H, Matsuo K: Increased blood vascular endothelial growth factor levels in patients with acute myocardial infarction. Cardiology 2000;93:93-99
31. Hojo Y, Ikeda U, Zhu Y, Okada M, Ueno S, Arakawa H, Fujikawa H, Katsuki T, Shimada K: Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J Am Coll Cardiol 2000;35:968-973
32. Servos S, Zachary I, Martin JF: VEGF modulates NO production: The basis of a cytoprotective effect? Cardiovavc Res 1999;41:509-510
33. Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL, Jain RK: During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med 1996;2:992-997
34. Swerlick RA, Swerlick RA: Angiogenesis. J Dermatol 1995;22:845-852